65,437 trials
Influenza, Human
Primary: Number of Participants Reporting Any Solicited Administration Site Adverse Event — 44 Participants
Hidradenitis Suppurativa
Primary: HS Physician Local Improvement Assessment - PAIN — 7; 7; 2 Participants
Parkinson Disease
Primary: Change From Baseline in Domain 3 (Fluctuation-related Pain) of KING's PARKINSON's DISEASE PAIN SCALE (KPPS) — 17.2; 16.7; 17.1; 16.9 score on a scale
Human Immunodeficiency Virus I Infection · Immunodeficiency Virus Type 1, Human · Human Immunodeficiency Virus Type 1
Primary: Number and Types of Adverse Events (AEs), Including Serious Adverse Events (SAEs), and AEs Leading to Treatment Discontinuation in Participants Receiving MGD020 Alone in…
Nonexudative Age-Related Macular Degeneration, Unspecified Eye, Intermediate Dry Stage
Primary: BCVA Response Defined as an Increased in 10 Letters at 1 Year Post-implant — 3; 3; 1; 9 eyes
Renal Cell Carcinoma
Primary: Age of Participants at Baseline — 71.0 years
Edentulous Mouth · Dental Prosthesis Failure
Primary: Survival Rate of Dentures With SR Phonares II Teeth — 17 Participants
Musculoskeletal Pain
Primary: Chronic Pain Severity — 4.33; 5; 4.39; 4.22 score on a scale — p=0.83
COVID-19 · Vaccine Uptake
Primary: COVID Vaccine Uptake at Month 1 — 6; 5 Participants
Endometrial Cancer · Survivorship
Primary: Number of Participants to Complete Intervention - Feasibility — 42 Participants
Atopic Dermatitis
Primary: To Evaluate and Confirm the Performance of the Relizema Cream in the Improvement of the Dermatitis Severity in Paediatric Patients. — 17; 13 Participants
Gastroenteropancreatic Neuroendocrine Tumor
Primary: Prevalence of Malnutrition in GEP NET — 247; 152 Participants
Kidney Diseases · Kidney Injury · Kidney Failure
Primary: Correlation of Transdermal Derived Glomerular Filtration Rate (tGFR) to the Plasma-derived Indexed Glomerular Filtration Rate (nGFR) — 0.950; 0.971 Proportion of tGFR…
Emotion Regulation · Coping Skills
Primary: Acceptability of Intervention Measure — 4.36 units on a scale
Diabetes Mellitus, Type 2
Primary: Occurrence of Urinary Tract Cancer — 0.73; 1.07; 1.34; 1.52 Events per 1000 patient years — p=0.122